Early metabolic impairment as a contributor to neurodegenerative disease: Mechanisms and potential pharmacological intervention-Reference-Cited by-同舟云学术

Early metabolic impairment as a contributor to neurodegenerative disease: Mechanisms and potential pharmacological intervention

Published:2022-04-26 Issue:5 Volume:30 Page:982-993
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:Obesity

Author:

Fakih Walaa¹²,Zeitoun Ralph²,AlZaim Ibrahim²³,Eid Ali H.⁴⁵,Kobeissy Firas³⁶,Abd‐Elrahman Khaled S.⁷⁸⁹,El‐Yazbi Ahmed F.²⁸¹⁰^ORCID

Affiliation:

1. Faculty of Pharmacy Federation of Translational Medicine of Strasbourg University of Strasbourg Illkirch France

2. Department of Pharmacology and Toxicology Faculty of Medicine American University of Beirut Beirut Lebanon

3. Department of Biochemistry and Molecular Genetics Faculty of Medicine American University of Beirut Beirut Lebanon

4. Department of Basic Medical Sciences College of Medicine Qatar University Doha Qatar

5. Biomedical and Pharmaceutical Research Unit QU Health Qatar University Doha Qatar

6. Program for Neurotrauma Neuroproteomics & Biomarkers Research Departments of Emergency Medicine, Psychiatry, Neuroscience and Chemistry University of Florida Gainesville Florida USA

7. Brain and Mind Research Institute Department of Cellular and Molecular Medicine University of Ottawa Ottawa Ontario Canada

8. Department of Pharmacology and Toxicology Faculty of Pharmacy Alexandria University Alexandria Egypt

9. Department of Pharmacology and Therapeutics College of Medicine and Health Science Khalifa University Abu Dhabi United Arab Emirates

10. Department of Pharmacology and Toxicology Faculty of Pharmacy Alamein International University New Alamein City Egypt

Funder

American University of Beirut

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/oby.23400

Reference100 articles.

1. The Cardiometabolic Syndrome and Cardiovascular Disease

2. Impact of Metabolic Syndrome on Neuroinflammation and the Blood–Brain Barrier

3. Prediabetes and diabetes accelerate cognitive decline and predict microvascular lesions: A population‐based cohort study

4. Targeting perivascular and epicardial adipose tissue inflammation: therapeutic opportunities for cardiovascular disease

5. Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Astrocyte response to melatonin treatment in rats under high-carbohydrate high-fat diet;Journal of Chemical Neuroanatomy;2024-03

2. Chronic and postprandial effect of blueberries on cognitive function, alertness, and mood in participants with metabolic syndrome – results from a six-month, double-blind, randomized controlled trial;The American Journal of Clinical Nutrition;2024-02

3. The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation;Ageing Research Reviews;2023-11

4. Associations of metabolic syndrome, its severity with cognitive impairment among hemodialysis patients;Diabetology & Metabolic Syndrome;2023-05-23

5. mTOR/α-ketoglutarate signaling: impact on brain cell homeostasis under ischemic conditions;Frontiers in Cellular Neuroscience;2023-05-11